Riskpilot← Back to searchSign inGet full accessBioSolv Aktiebolag
ABIn liquidationOrg 5564588845Engineering activities and related technical consultancy · NACE 7112Est. 19930 employees
Revenue 2024
SEK 0
EBITDA margin
—
-18% vs 2023
Equity ratio
61.7%
Financial strength
Net profit 2024
SEK -10K
-18% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -10K | -18% |
| Net profit | SEK -10K | -18% |
| Total assets | SEK 127K | -7% |
| Equity | SEK 78K | -11% |
| Employees | 0 | — |
Legal name
BioSolv Aktiebolag
Org number
5564588845
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
8 mars 1993
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall bedriva konsultverksamhet inom hästnäring och sjukvård, personaluthyrning, äga och förvalta fast och lös egendom samt aktier och därmed förenlig verksamhet.
Address
Phone
+4686059919
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −6 | −7 | −3 | −9 | −10 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −6 | −7 | −3 | −9 | −10 |
| Net financials | — | — | −0 | −0 | 0 |
| Profit before tax | −6 | −7 | −3 | −9 | −10 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −6 | −7 | −3 | −9 | −10 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 156 | 145 | 146 | 137 | 127 |
| Equity | 108 | 100 | 97 | 88 | 78 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 49 | 45 | 49 | 49 | 49 |
| Total debt | 49 | 45 | 49 | 49 | 49 |
EBITDA margin
-1008300.0%
This company
15.8%
Market median
-6381746% vs market
20202024
Equity ratio
61.7%
This company
38.2%
Market median
+62% vs market
20202024
Return on equity
-12.9%
This company
18.4%
Market median
-170% vs market
20202024
Net profit margin
-1007900.0%
This company
8.1%
Market median
-12443310% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.62×
This company
0.62×
Market median
+0% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RA Liquidator | Liquidator | 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BioSolv Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Allan Skoglund | Liquidator | 0 companies |
| Disa Sofi Magdalena Adielsson | Board of Directors | 0 companies |
| Erik Olof Adielsson | Deputy Board Member | 0 companies |
| Ingrid Margareta Eriksson Karth | Deputy Board Member | 0 companies |